BibTex format
@article{Peters:2022:10.1016/j.annonc.2021.09.011,
author = {Peters, S and Pujol, J-L and Dafni, U and Domine, M and Popat, S and Reck, M and Andrade, J and Becker, A and Moro-Sibilot, D and Curioni-Fontecedro, A and Molinier, O and Nackaerts, K and Molla, AI and Gervais, R and Lopez, Vivanco G and Madelaine, J and Mazieres, J and Faehling, M and Griesinger, F and Majem, M and Gonzalez, Larriba JL and Provencio, Pulla M and Vervita, K and Roschitzki-Voser, H and Ruepp, B and Mitchell, P and Stahel, RA and Le, Pechoux C and De, Ruysscher D},
doi = {10.1016/j.annonc.2021.09.011},
journal = {ANNALS OF ONCOLOGY},
pages = {67--79},
title = {Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial},
url = {http://dx.doi.org/10.1016/j.annonc.2021.09.011},
volume = {33},
year = {2022}
}